Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets
- 30 January 1989
- journal article
- Published by Wiley in FEBS Letters
- Vol. 243 (2) , 244-246
- https://doi.org/10.1016/0014-5793(89)80137-1
Abstract
The present study investigated the mechanism by which eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) inhibit platelet activation induced by thromboxane A2. DHA was found to be more potent than EPA in blocking platelet aggregation induced by the stable thromboxane A2 mimetic, U46619. Furthermore, this inhibition by DHA or EPA was competitive. Binding studies using 3H-U46619 demonstrated that both EPA and DHA interact with the platelet thromboxane receptor. The potency of the inhibition of binding corresponded with that seen for the inhibition of aggregation. These results suggest that thromboxane receptor antagonism may be an important mechanism by which EPA and DHA modulate platelet reactivity in vivo.Keywords
This publication has 14 references indexed in Scilit:
- Interference of eicosapentaenoic and docosahexaenoic acids with arachidonate- and U46619-induced platelet activation and desensitizationBiochemical Pharmacology, 1988
- Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated processBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987
- A photoaffinity label for the thromboxane A2 /prostaglandin H2 receptor in human blood plateletsFEBS Letters, 1987
- Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548)Thrombosis Research, 1986
- Effects of long-chain cis-unsaturated fatty acids and their alcohol analogs on aggregation of bovine platelets and their relation with membrane fluidity changeBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acidsBiochemical and Biophysical Research Communications, 1983
- Effects of all CIS-5, 8,11,14,17 eicosapentaenoic acid and PGH3 on platelet aggregationProstaglandins, 1979
- EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS?Published by Elsevier ,1978
- SOME QUANTITATIVE USES OF DRUG ANTAGONISTSBritish Journal of Pharmacology and Chemotherapy, 1959